GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹10,618 Cr | ₹9,948 Cr | ₹9,985 Cr | ₹8,860 Cr | ₹8,943 Cr |
What is the latest Total Expenditure of GLENMARK PHARMACEUTICALS ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹10,618 Cr |
| Mar2024 | ₹9,948 Cr |
| Mar2023 | ₹9,985 Cr |
| Mar2022 | ₹8,860 Cr |
| Mar2021 | ₹8,943 Cr |
How is Total Expenditure of GLENMARK PHARMACEUTICALS Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹10,618 Cr | 6.73 | |
| Mar2024 | ₹9,948 Cr | -0.36 | |
| Mar2023 | ₹9,985 Cr | 12.70 | |
| Mar2022 | ₹8,860 Cr | -0.93 | |
| Mar2021 | ₹8,943 Cr | - | |
Compare Total Expenditure of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹61,110.4 Cr | -1.6% | -8.8% | 49.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,933.0 Cr | -0.7% | -3.6% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,833.0 Cr | 1.1% | -1.2% | -0.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,549.0 Cr | 1.6% | 1.4% | 36.7% | Stock Analytics | |
| CIPLA | ₹113,155.0 Cr | 0.7% | 2.6% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,652.0 Cr | -0.9% | -2.5% | 1.2% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -1.6% |
-8.8% |
49.7% |
| SENSEX | -0.7% |
-3.6% |
-9.1% |
You may also like the below Video Courses